Page last updated: 2024-12-11

lipstatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lipstatin: isolated from Streptomyces toxytricini; inhibitor of pancreatic lipase; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9805651
CHEMBL ID5174296
SCHEMBL ID113230
MeSH IDM0153101

Synonyms (14)

Synonym
lipstatin
96829-59-3
SCHEMBL113230
AKOS030528305
CHEMBL5174296 ,
[(2s,4z,7z)-1-[(2s,3s)-3-hexyl-4-oxooxetan-2-yl]trideca-4,7-dien-2-yl] (2s)-2-formamido-4-methylpentanoate
Q6557065
l-leucine, n-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)-3,6-dodecadienyl ester, (2s-(2.alpha.(1r*,3z,6z),3.beta.))-
l-leucine, n-formyl-, (1s,3z,6z)-1-(((2s,3s)-3-hexyl-4-oxo-2-oxetanyl)methyl)-3,6-dodecadienyl ester
l-leucine, n-formyl-,(1s,3z,6z)-1-[[(2s,3s)-3-hexyl-4-oxo-2-oxetanyl]methyl]-3,6-dodecadienyl ester
bdbm50595125
CS-0021122
HY-N2330
(s)-(s,4z,7z)-1-((2s,3s)-3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl 2-formamido-4-methylpentanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)0.14000.00401.10246.5000AID1873230
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1873230Inhibition of porcine pancreatic lipase using trioleate as substrate assessed as inhibition of substrate hydrolysis measured for 10 mins2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.76)18.7374
1990's1 (4.76)18.2507
2000's6 (28.57)29.6817
2010's10 (47.62)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.40 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]